.Atea Pharmaceuticals' antiviral has actually failed yet another COVID-19 trial, however the biotech...
.Neurocrine Biosciences' mental illness course pivot has actually stopped working. The biotech was a...
.Sanofi has actually made a late entrance to the radioligand party, spending 100 thousand europeans ...
.After F2G's very first attempt to acquire a brand-new training class of antifungal to market was hi...
.Moderna has actually pledged to reduce R&D costs through $1.1 billion by 2027. The selection to ...
.Only 4 months after Sanofi wager $80 thousand in beforehand money on Key Therapeutics' losmapimod, ...
.Cancer cells firm Oncternal Therapies is actually folding all its own professional trials and givin...
.Roche is storing out chances that its injectable being overweight prospect can eventually demonstra...
.Novo Nordisk has actually elevated the top on a period 1 test of its own dental amylin and GLP-1 re...
.Just a couple of short weeks after succeeding an FDA Fast Track tag for its investigational BTK deg...